Company profile · Biotech & medical
Bora Pharmaceuticals
保瑞藥業股份有限公司 · 6472
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Bora Pharmaceuticals provides contract development and manufacturing organization (CDMO) services and global pharmaceutical sales.[1]
The company provides one-stop development, testing, certification, mass production, and delivery services for various pharmaceutical dosage forms across global facilities.[1]
Its global pharmaceutical sales cover multiple therapeutic areas, with a primary focus on specialty generic drugs and pediatric epilepsy specialty drugs in the United States, alongside branded and imported prescription drugs, over-the-counter drugs, and healthcare products in Taiwan.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$2.0bn | +15.9% | -14.4% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$889m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Bora Pharmaceuticals Co., Ltd. |
|---|---|
| Chinese name | 保瑞藥業股份有限公司 |
| Stock code | 6472 (TWSE) |
| Industry | Biotech & medical |
| Founded | 12 Jun 2007 |
| Listed | 19 Dec 2023 |
| Paid-in capital | NT$1.3bn |
| Chairman | 盛保熙 |
| President | 盛保熙 |
| Headquarters | 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd. Neihu Dist., Taipei City 114, Taiwan |
| Website | https://bora-corp.com/ |
| Official business description | 藥品製造、西藥及保健保養品代理及銷售 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Annual report 2025 (English), business scope · annual_report · retrieved 03 Nov 2026
Using it at work? Join the team-plan waiting list